(1R,2S,4S,5S)-PHOPHORIC-ACID-MONO-[4-(2-CHLORO-6-METHYLAMINO-PURIN-9-YL)-2-HYDROXY-BICYCLO-[3.1.0]-HEX-1-YL-METHYL]-ESTER
Compound with spectra: 1 NMR
![(1R,2S,4S,5S)-PHOPHORIC-ACID-MONO-[4-(2-CHLORO-6-METHYLAMINO-PURIN-9-YL)-2-HYDROXY-BICYCLO-[3.1.0]-HEX-1-YL-METHYL]-ESTER](/api/compound/K4Zr229ncLS.png?ph=true&h=300&w=458 "(1R,2S,4S,5S)-PHOPHORIC-ACID-MONO-[4-(2-CHLORO-6-METHYLAMINO-PURIN-9-YL)-2-HYDROXY-BICYCLO-[3.1.0]-HEX-1-YL-METHYL]-ESTER")
| SpectraBase Compound ID | K4Zr229ncLS |
|---|---|
| InChI | InChI=1S/C13H17ClN5O5P/c1-15-10-9-11(18-12(14)17-10)19(5-16-9)7-2-8(20)13(3-6(7)13)4-24-25(21,22)23/h5-8,20H,2-4H2,1H3,(H,15,17,18)(H2,21,22,23)/t6-,7+,8+,13-/m1/s1 |
| InChIKey | PYRJJXCDVGCPOH-QRMHULIRSA-N |
| Mol Weight | 389.74 g/mol |
| Molecular Formula | C13H17ClN5O5P |
| Exact Mass | 389.065583 g/mol |
| Enantiomer InChIKey | PYRJJXCDVGCPOH-PSWSROFUSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | D2O |
(1'S,2'R,3'S,4'R,5'S)-4-(6-AMINO-9H-PURIN-9-YL)-1-[PHOSPHORYLOXYMETHYL]-BICYCLO-[3.1.0]-HEXANE-2,3-DIOL
(1'R,2'R,3'R,4'R,5'S)-2-AMINO-6-CHLORO-9-[3'-ACETOXY-2'-BROMO-4'-(1'',2''-DIACETOXYETHYL)-CYCLOPENTAN-1'-YL]-PURINE
2-CHLORO-9-[2'-DEOXY-5'-O-(4,4'-DIMETHOXYTRITYL)-BETA-D-ERYTHRO-PENTOFURANOSYL]-6-([(DIMETHYLAMINO)-METHYLIDENE]-AMINO)-9H-PURINE-3'-TRIETHYLAMMONIUM-PHOSPHONA
[(5S,7R)-7-[[6-(cyclopropylamino)-9-purinyl]methyl]-1,4-diphenyl-6,7-dihydro-5H-cyclopenta[d]pyridazin-5-yl]methanol
6-O-Allyl-3',5'-bis-O-(tert-butyldimethylsilyl)-2'-deoxy-2-N-morpholinoguanosine
2-CHLORO-(2',3'-O-METHOXYMETHYLIDENE)-ADENOSINE
PARTHENOSTILBENIN_A
3-ACETYL-1-RIBOFURANOSYLPYRIDINIUM HYDROXIDE, 5' TO 5'-ESTER WITH ADENOSINE 5'-DIPHOSPHATE, INNER SALT, DIHYDRATE
Spiro[1,3-dioxolane-2,1'(8'aH)-naphthalene]-8'a-carboxylic acid, 4'-(benzoylamino)-2',3',4',4'a,5',8'-hexahydro-, methyl ester, [4'R-(4'.alpha.,4'a.alpha.,8'a.alpha.)]-
Guanosine 3',5'-cyclic phosphate anion
| Title | Journal or Book | Year |
|---|---|---|
| Acyclic Analogues of Adenosine Bisphosphates as P2Y Receptor Antagonists: Phosphate Substitution Leads to Multiple Pathways of Inhibition of Platelet Aggregation | Journal of Medicinal Chemistry | 2002 |